A pill embedded with a sensor that can telldoctors—and potentially others—if and when a patient takes his orher medication, recently approved by the U.S. Food and Drug Administration, is touted as asolution to prescription medication nonadherence, which costs theAmerican health care system between $100 billion and $289 billion ayear, according to a review in Annals of Internal Medicine. Andthose are just the financial costs. It also causes about 125,000deaths annually, the article says.

While acknowledging the medical and financial benefits of theso-called digital pill, health care and data privacy lawyersexpressed concerns about data security and patient consent.

“The slippery slope danger is really real,” said MichaelWhitener, a data privacy expert and partner at VLP LawGroup.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Kristen Rasmussen

Kristen Rasmussen is an Atlanta-based reporter who covers corporate law departments and in-house attorneys.